Astex Pharmaceuticals
Focus: Astex Pharmaceuticals is a UK-based public pharmaceutical company specializing in fragment-based drug discovery with a focus on oncology and hematologic malignancies. The company operates a diversified pipeline of small-molecule candidates targeting high-unmet-need cancer indications.
Profile data last refreshed 20h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
About Astex Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Astex Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Astex Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
multitargeted receptor tyrosine kinase inhibitor MP470
LymphomaClinical Trials (1)
NCT00504205MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma
N/AHelp build intelligence for Astex Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.